Allumiqs
Allumiqs is a Canadian contract research organization providing multiomics and bioanalytical services — proteomics, metabolomics, and lipidomics — to pharmaceutical and biotech companies, using LC-MS/MS workflows and the Alamar ARGO HT + NULISA platform, alongside MagReSyn® product distribution across North America.
- Company typePrivate
- Founded2018
- HeadquartersHalifax, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Allumiqs does
Allumiqs is a Canadian contract research organization (CRO) headquartered in Halifax, Nova Scotia, with a second office in Sherbrooke, Québec, founded in 2018. The firm serves pharmaceutical and biotechnology companies engaged in drug discovery and development by delivering multiomics and bioanalytical services — proteomics, metabolomics, lipidomics, and integrated multiomics — built on LC-MS/MS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry) workflows, complemented by high-sensitivity biomarker assays run on the Alamar Biosciences ARGO HT + NULISA platform as a Certified Service Provider, achieving attomolar-level detection and 200-plex multiplexing.
The company's underlying technology combines mass spectrometry-based omics with oligonucleotide-linked antibody immunoassays and dual magnetic capture, supported by a data analytics pipeline with 25 embedded quality checkpoints that converts raw LC-MS/MS output into interpretive reports with next-step recommendations. Allumiqs also sells MagReSyn® ultra-capacity magnetic microparticles and the Mag-Net™ HP Kit 96 through an e-commerce storefront as the authorized North American distributor for the product line, and operates a registered supplier listing on the Scientist.com marketplace for procurement-channel access.
Revenue is generated through two streams: (1) quote-based professional services for bioanalytical and multiomics projects under multi-year contracts, and (2) unit-priced product sales for MagReSyn® consumables (ranging from $85 to $4,800 per unit). The company pursues a sales-led, enterprise-focused go-to-market via direct outreach, channel partnerships, and scientific content marketing, targeting primarily pharma and biotech R&D organizations with secondary reach into academic and CRO clients.
Allumiqs firmographics
Firmographics- Name
- Allumiqs
- Legal name
- Allumiqs Corporation
- Website
- https://allumiqs.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Allumiqs is a Canadian contract research organization providing multiomics and bioanalytical services — proteomics, metabolomics, and lipidomics — to pharmaceutical and biotech companies, using LC-MS/MS workflows and the Alamar ARGO HT + NULISA platform, alongside MagReSyn® product distribution across North America.
- Ownership category
- akta.pro rank
Allumiqs industry classification
Industry- Product category
- Contract Research & Bioanalytical Services
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)
Keywords
Where Allumiqs is headquartered
LocationHeadquarters
- HQ city
- Halifax
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Allumiqs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Bioanalytical and Omics Services: Contract research services providing multiomics analysis (proteomics, metabolomics, lipidomics) using LC-MS/MS and the ARGO HT + NULISA platform for biomarker discovery, validation, and drug development support.
- MagReSyn® Products: Sale of MagReSyn® magnetic microparticles and sample preparation products for omics research, including various functional beads (Hydroxyl, Ti-IMAC HP, Zr-IMAC HP, Streptavidin, Protein A/G, HILIC, Amine, Carboxyl, Trypsin, TiO2, ZrO2, NTA) and ProTrap XG cartridges.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | MagReSyn® microparticles and sample prep products with unit pricing based on product type and volume |
| Other | Multi-year contract | Custom bioanalytical service pricing (quote-based) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Allumiqs product offering
Product offeringCore offering
Allumiqs is a contract research organization (CRO) that provides integrated multiomics and bioanalytical services to pharmaceutical and biotech companies, spanning proteomics, metabolomics, lipidomics, and small molecule analysis using LC-MS/MS and the ARGO HT + NULISA high-sensitivity immunoassay platform. The company also distributes MagReSyn magnetic microparticles and sample preparation kits through an e-commerce storefront as an authorized North American distributor.
Product overview
Allumiqs provides a dual offering: (1) a portfolio of MagReSyn® ultra-capacity magnetic microparticle products for omics sample preparation — including the Mag-Net™ HP kit for membrane vesicle enrichment and the ProTrap XG universal sample prep cartridges — which are sold through its e-commerce shop; and (2) contract research services centered on LC-MS/MS-based proteomics, metabolomics, lipidomics, and multiomics analysis. The High Sensitivity Biomarker Assay, powered by the Alamar Biosciences ARGO™ HT platform and NULISA™ technology, extends Allumiqs' service portfolio into ultra-high-sensitivity immunoassay territory as a certified service provider, enabling customers to access attomolar-level biomarker detection that complements the mass spec workflow.
Differentiator
Problem solved
Functional benefit
Products and services
- High Sensitivity Biomarker Assay (ARGO HT + NULISA) Certified service offering combining the ARGO HT system with NULISA immunoassay platform, delivering attomolar-level biomarker detection (down to ~10 aM) and broad multiplexing (200+ targets) for plasma, CSF, and other biofluids. Available to pharmaceutical and biotech clients through Allumiqs as an Alamar Biosciences Certified Service Provider.
- Integrated Multiomics CRO Services Contract research organization services that combine proteomics, metabolomics, lipidomics, and small molecule analysis using LC-MS/MS workflows to support biomarker discovery, target validation, drug mechanism of action studies, PK/PD bioanalysis, protein characterization, and multiomics data analytics. Designed for pharmaceutical, biotech, and academic research organizations.
- Mag-Net HP – Kit 96 Kit for deep proteome profiling of biofluids such as plasma via enrichment of membrane-bound vesicles. Enables automated or manual enrichment of 96 samples. For researchers in proteomics and biomarker discovery workflows.
- ProTrap XG – Universal Sample Prep Cartridges Universal sample preparation cartridges for streamlined processing of biological samples prior to LC-MS/MS analysis. For proteomics and bioanalytical research laboratories.
- MagReSyn Magnetic Microparticles (Product Family) A family of ultra-capacity magnetic microparticles for omics sample preparation sold in multiple functional variants (Hydroxyl, Ti-IMAC HP, Zr-IMAC HP, Streptavidin, Protein A/G, HILIC, SAX, NTA, TiO2, ZrO2, Amine, Carboxyl, Trypsin). Used for phosphopeptide enrichment, protein capture, antibody purification, and metabolite/interactomics workflows. For research laboratories and CRO customers.
Quantifiable outcome
- 10,000-fold sensitivity improvement over conventional proximity assays
- +3 more outcomes
Companies that use Allumiqs
Customer profileSegments2 records
Ideal customer profiles2 records
Allumiqs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Allumiqs partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supportive.
- Alamar BiosciencescoreAllumiqs is a Certified Service Provider (CSP) for Alamar Biosciences, validated to deliver highly sensitive, rigorously validated NULISA assay services on the ARGO HT platform. This partnership provides access to the latest technology, training, and best practices for ultra-sensitive biomarker detection.
- MagReSyn® (ReZult Scientific)coreAllumiqs is an authorized North American distributor of MagReSyn® ultra capacity microparticles for omics sample preparation. The company routinely uses MagReSyn® products as part of customer solutions and resells them through their online store.
- Scientist.comsupportiveAllumiqs is a registered supplier on Scientist.com marketplace, enabling organizations that use the platform for scientific procurement to connect with and purchase from Allumiqs.
Scale indicators1 record
Recent moves1 record
Expansion highlights5 records
Allumiqs competitors and assessment
Company assessmentDirect peers
- Biognosys: Swiss-based proteomics CRO offering LC-MS/MS-based protein quantification, biomarker discovery, and bioinformatic analysis to pharma/biotech clients. Most directly comparable to Allumiqs in business model, technology stack, and target customer base.
- Metabolon: US-based metabolomics CRO providing small molecule profiling and biomarker discovery services to pharmaceutical, biotech, and academic clients. Direct peer to Allumiqs for metabolomics within the multiomics stack.
- SomaLogic (Standard BioTools): Protein biomarker discovery company using aptamer-based SomaScan platform for high-plex proteomics. Operates both as a platform vendor and provides assay services, comparable to Allumiqs in protein biomarker detection services for pharma pipelines.
- Olink: Swedish proteomics company offering proximity extension assay (PEA) technology for high-plex protein biomarker detection. Provides both reagent kits and service offerings through Olink Explore and Olink Signature, comparable to Allumiqs' NULISA offering in high-sensitivity biomarker detection.
Broad incumbents
- Eurofins Scientific: Global testing laboratory network with broad life sciences, food, and pharma service portfolio including bioanalytical and biomarker services. Much larger competitor with overlapping capabilities but far broader scope and global footprint.
- Charles River Laboratories: Major contract research organization providing discovery, safety assessment, and manufacturing services to pharma/biotech. Overlaps with Allumiqs in discovery-stage bioanalytical and protein characterization services, but with vastly broader portfolio.
- IQVIA: Largest global CRO with full-service discovery through clinical capabilities, including laboratory services and bioanalytical offerings. Competes with Allumiqs for pharma discovery contracts but with much broader scope and enterprise scale.
- LabCorp (Covance Drug Development): Major clinical diagnostics and drug development services company with extensive bioanalytical laboratory offerings for pharma/biotech. Overlaps with Allumiqs in biomarker and bioanalytical services but operates at much larger scale.
- Cell Signaling Technology: US-based life sciences company specializing in antibodies and proteomics research tools including PTM analysis and signaling pathway assays. Comparable technology overlap with Allumiqs' protein characterization capabilities and serves similar pharma/research customers.
- Bruker: Scientific instrument manufacturer with strong mass spectrometry portfolio (timsTOF, timsMetabo) and recently expanded proteomics services following NanoString acquisition. Both a potential technology supplier and competitor in the proteomics services space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Allumiqs social profiles
Digital presenceAllumiqs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Allumiqs leadership team
Management profileNumber of profiles
Profiles1 record
Allumiqs funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Allumiqs M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Allumiqs
What does Allumiqs do?
Allumiqs is a contract research organization (CRO) that provides integrated multiomics and bioanalytical services to pharmaceutical and biotech companies, spanning proteomics, metabolomics, lipidomics, and small molecule analysis using LC-MS/MS and the ARGO HT + NULISA high-sensitivity immunoassay platform. The company also distributes MagReSyn magnetic microparticles and sample preparation kits through an e-commerce storefront as an authorized North American distributor.
Is Allumiqs a public or private company?
Allumiqs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Allumiqs founded?
Allumiqs was founded in 2018. It employs 11 to 50 people.
Where is Allumiqs based?
Allumiqs is headquartered in Halifax, Canada, in the North America region.
How does Allumiqs make money?
Two revenue lines are on record. Bioanalytical and Omics Services are the primary driver. The others are magReSyn® Products.
Who are Allumiqs's main competitors?
Direct peers on record are Biognosys, Metabolon, SomaLogic (Standard BioTools) and Olink. Broad incumbents are Eurofins Scientific, Charles River Laboratories, IQVIA, LabCorp (Covance Drug Development), Cell Signaling Technology and Bruker.
Does Allumiqs have an API?
No public API is recorded for Allumiqs.
What industry is Allumiqs in?
Allumiqs's product category is Contract Research & Bioanalytical Services. Its primary akta.pro industry code is AFALAAAA, Food Testing Laboratories (Microbiological, Chemical, Allergen). Its NAICS code is 334516 and its SIC code is 8734.